Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin–Yang interplay between inflammation and cancer

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Oncogene

• Publication date

  2010-06-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/onc.2010.109PMID 20400974
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumorigenesis and Neoplastic Progression A Novel Mouse Model of Inflammatory Bowel Disease Links Mammalian Target of Rapamycin-Dependent Hyperproliferation of Colonic Epithelium to Inflammation-Associated Tumorigenesis

  2010cited by this paper
• Immunogenic death of colon cancer cells treated with oxaliplatin

  2010cited by this paper
• Long-term safety of Infliximab for the treatment of inflammatory bowel disease: does blocking TNFa reduce colitis-associated colorectal carcinogenesis?

  2009cited by this paper
• Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells.

  2009cited by this paper
• TIR8/SIGIRR: an IL-1R/TLR family member with regulatory functions in inflammation and T cell polarization.

  2009cited by this paper
• Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis

  2009cited by this paper
• Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

  2009cited by this paper
• Long-term safety of Infliximab for the treatment of inflammatory bowel disease: does blocking TNFα reduce colitis-associated colorectal carcinogenesis?

  2009cited by this paper
• CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.

  2009cited by this paper
• gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.

  2009cited by this paper
• The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6

  2009cited by this paper
• Tumour necrosis factor and cancer

  2009cited by this paper
• Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression.

  2009cited by this paper
• IKK/NF‐κB and STAT3 pathways: central signalling hubs in inflammation‐mediated tumour promotion and metastasis

  2009cited by this paper
• IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

  2009cited by this paper
• Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice.

  2009cited by this paper
• Toll-like receptors and cancer

  2009cited by this paper
• Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability.

  2009cited by this paper
• Inflammatory bowel disease and mutations affecting the interleukin-10 receptor.

  2009cited by this paper
• NF-kappaB and cancer-identifying targets and mechanisms.

  2008cited by this paper
• Cancer: Inflaming metastasis

  2008cited by this paper
• Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid.

  2008cited by this paper
• Oxidative stress in ulcerative colitis-associated carcinogenesis.

  2008cited by this paper
• Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.

  2008cited by this paper
• IKK/NF-κB signaling in intestinal epithelial cells controls immune homeostasis in the gut

  2008cited by this paper
• Cancer-related inflammation

  2008influential reference
• Molecular basis of the potential of mesalazine to prevent colorectal cancer.

  2008cited by this paper
• Role of Toll-like receptors in gastrointestinal malignancies

  2008cited by this paper
• Inflammation: gearing the journey to cancer.

  2008cited by this paper
• Colitis and cancer: a tale of inflammatory cells and their cytokines.

  2008cited by this paper
• Regulation of Spontaneous Intestinal Tumorigenesis Through the Adaptor Protein MyD88

  2007cited by this paper
• Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors.

  2007cited by this paper
• Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

  2007cited by this paper
• The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis.

  2007cited by this paper
• Increased susceptibility to colitis-associated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family.

  2007cited by this paper
• The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors.

  2007cited by this paper
• Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon

  2007cited by this paper
• Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6

  2007cited by this paper
• Transforming growth factor-beta induces development of the T(H)17 lineage.

  2006cited by this paper
• TGF-beta as a T cell regulator in colitis and colon cancer.

  2006influential reference
• TNF-α in promotion and progression of cancer

  2006cited by this paper
• Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules.

  2006cited by this paper
• Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

  2006cited by this paper
• Nuclear factor-kappaB in cancer development and progression.

  2006cited by this paper
• TNF-alpha in promotion and progression of cancer.

  2006cited by this paper
• Protein phosphatase 2A is required for mesalazine-dependent inhibition of Wnt/beta-catenin pathway activity.

  2006cited by this paper
• Nuclear factor-κB in cancer development and progression

  2006cited by this paper
• Colon cancer and the immune system: the role of tumor invading T cells.

  2006cited by this paper
• Predominant T helper type 2‐inflammatory responses promote murine colon cancers

  2006cited by this paper
• Tuning inflammation and immunity by chemokine sequestration: decoys and more

  2006cited by this paper
• Tumour necrosis factor-alpha as a tumour promoter.

  2006cited by this paper
• Tumour necrosis factor-α as a tumour promoter

  2006cited by this paper
• Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

  2006cited by this paper
• Involvement of Proinflammatory Cytokines IL-1β and IL-6 in Progression of Human Gastric Carcinoma

  2005cited by this paper
• Macrophage polarization comes of age.

  2005cited by this paper
• Toll-like receptors on tumor cells facilitate evasion of immune surveillance.

  2005influential reference
• Directing Transition from Innate to Acquired Immunity: Defining a Role for IL-61

  2005cited by this paper
• Involvement of proinflammatory cytokines IL-1beta and IL-6 in progression of human gastric carcinoma.

  2005cited by this paper
• Smoldering and polarized inflammation in the initiation and promotion of malignant disease.

  2005cited by this paper
• The IKK/NF-κB activation pathway—a target for prevention and treatment of cancer

  2004cited by this paper
• Expression of both TNF-α receptor subtypes is essential for optimal skin tumour development

  2004cited by this paper
• The chemoprevention of colorectal carcinoma

  2004cited by this paper
• ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance

  2004cited by this paper
• The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer.

  2004cited by this paper
• The Spectrum of Gastrointestinal Toxicity and Effect on Disease Activity of Selective Cyclooxygenase-2 Inhibitors in Patients with Inflammatory Bowel Disease

  2004cited by this paper
• Extracellular and intracellular decoys in the tuning of inflammatory cytokines and Toll‐like receptors: the new entry TIR8/SIGIRR

  2004cited by this paper
• Role of cyclooxygenase-2 in colorectal cancer

  2004cited by this paper
• Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development.

  2004cited by this paper
• Review article: the chemoprevention of colorectal carcinoma.

  2004cited by this paper
• The interface between innate and adaptive immunity

  2004cited by this paper
• TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

  2004cited by this paper
• Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family.

  2004cited by this paper
• TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling

  2004cited by this paper
• Differential Recognition and Scavenging of Native and Truncated Macrophage-Derived Chemokine (Macrophage-Derived Chemokine/CC Chemokine Ligand 22) by the D6 Decoy Receptor1

  2004cited by this paper
• SIGIRR, a negative regulator of Toll-like receptor–interleukin 1 receptor signaling

  2003influential reference
• Unique pattern of expression and inhibition of IL-1 signaling by the IL-1 receptor family member TIR8/SIGIRR.

  2003influential reference
• Interplay between IFN-γ and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation

  2003influential reference
• Tumour necrosis factor α: a potential target for the therapy of solid tumours

  2003cited by this paper
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.

  2003cited by this paper
• Serum interleukin‐6 levels reflect the disease status of colorectal cancer

  2003cited by this paper
• Chemokines

  2002cited by this paper
• Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells.

  2002cited by this paper
• Dysplasia and carcinoma development in a repeated dextran sulfate sodium‐induced colitis model

  2002cited by this paper
• Inflammation and cancer

  2002cited by this paper
• Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.

  2002cited by this paper
• Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation.

  2001cited by this paper
• Inflammation and cancer: back to Virchow?

  2001influential reference
• Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines.

  2001cited by this paper
• Cancer risk in patients with inflammatory bowel disease

  2001cited by this paper
• The risk of colorectal cancer in ulcerative colitis: a meta-analysis

  2001cited by this paper
• The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors.

  2001cited by this paper
• Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.

  2000cited by this paper
• Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys

  2000cited by this paper
• Differential Alteration in Intestinal Epithelial Cell Expression of Toll-Like Receptor 3 (TLR3) and TLR4 in Inflammatory Bowel Disease

  2000cited by this paper
• International union of pharmacology. XXII. Nomenclature for chemokine receptors.

  2000cited by this paper
• The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.

  2000cited by this paper
• Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo

  2000cited by this paper
• Short Communication Increased Expression of IP-10, IL-8, MCP-1, and MCP-3 in Ulcerative Colitis

  1999cited by this paper
• Inhibition of Interleukin-1-stimulated NF-κB RelA/p65 Phosphorylation by Mesalamine Is Accompanied by Decreased Transcriptional Activity*

  1999cited by this paper

• Dynamic variation in a combined inflammation–tumor marker index during neoadjuvant chemotherapy and its value for organ-preservation decisions in gastric cancer

  2026cites this paper
• Evodiamine relieves ulcerative colitis through reinventing the communication of "host-gut microbiota-macrophages".

  2025cites this paper
• Phellinus linteus (Agaricomycetes) Polysaccharides Ameliorate Inflammatory Injury in H2O2-Induced Caco-2 Cells and DSS-Induced Ulcerative Colitis Mice.

  2025cites this paper
• Therapeutic potential of flavonoids in gastrointestinal cancer: Focus on signaling pathways and improvement strategies (Review)

  2025cites this paper
• Targeting cyclooxygenase-2 for chemoprevention of inflammation-associated intestinal carcinogenesis: An update.

  2024cites this paper
• Computational prediction of new therapeutic effects of probiotics

  2024cites this paper
• SIRT1: a novel regulator in colorectal cancer.

  2024cites this paper
• Transient receptor potential melastatin 2 is involved in trinitrobenzene sulfonic acid-induced acute and chronic colitis-associated fibrosis progression in mice.

  2024cites this paper
• Inflammatory bowel disease, colitis, and cancer: unmasking the chronic inflammation link

  2024cites this paper
• Protective effects of insoluble dietary fiber from cereal bran against DSS-induced chronic colitis in mice: From inflammatory responses, oxidative stress, intestinal barrier, and gut microbiota.

  2024cites this paper
• Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two‐sample Mendelian randomization analysis of European and East Asian populations

  2023cites this paper
• Regulation of Staphylococcal Enterotoxin-Induced Inflammation in Spleen Cells from Diabetic Mice by Polyphenols

  2023cites this paper
• Nanomedicines: intervention in inflammatory pathways of cancer

  2023cites this paper
• Managing the older adult with inflammatory bowel disease: is age just a number?

  2023cites this paper
• Influence of food emulsifiers on cellular function and inflammation, a preliminary study

  2023cites this paper
• Intestinal epithelial cell autophagy deficiency suppresses inflammation-associated colon tumorigenesis

  2022influential citation
• Immune–related biomarkers shared by inflammatory bowel disease and liver cancer

  2022cites this paper
• N-Acetyldopamine Dimer Attenuates DSS-Induced Ulcerative Colitis by Suppressing NF-κB and MAPK Pathways

  2022cites this paper
• The Emerging Role of Janus Kinase Inhibitors in the Treatment of Cancer.

  2022cites this paper
• Targeting Pathogenic Inflammation for Therapeutic Intervention Against Colon Cancer

  2022cites this paper
• Risk of Cancer in Inflammatory Bowel Disease and Pitfalls in Oncologic Therapy

  2022cites this paper
• Antioxidation and anti-inflammatory actions of the extract of Nitraria Tangutorum Bobr. fruits reduce the severity of ulcerative colitis in a dextran sulphate sodium-induced mice model

  2022cites this paper
• Sequential self-assembly and disassembly of curcumin hydrogel effectively alleviates inflammatory bowel disease.

  2022cites this paper
• Colon Cancer Pharmacogenetics: A Narrative Review

  2022cites this paper
• Bee venom induces anti-tumor effects in HT-29 colon cancer cells through regulation of cell proliferation and apoptosis

  2022cites this paper
• Potential effects of fructus aurantii ethanol extracts against colitis-associated carcinogenesis through coordination of Notch/NF-κB/IL-1 signaling pathways.

  2022cites this paper
• Regulatory Components of Oxidative Stress and Inflammation and Their Complex Interplay in Carcinogenesis

  2022cites this paper
• Deletion of cystathionine-γ-lyase in bone marrow-derived cells promotes colitis-associated carcinogenesis

  2022cites this paper
• Bamboo Shoot and Artemisia capillaris Extract Mixture Ameliorates Dextran Sodium Sulfate-Induced Colitis

  2022cites this paper
• Chemically Induced Colitis-Associated Cancer Models in Rodents for Pharmacological Modulation: A Systematic Review

  2022cites this paper
• Activation of the GPR35 pathway drives angiogenesis in the tumour microenvironment

  2021cites this paper
• Flower extract of Caragana sinica. ameliorates DSS-induced ulcerative colitis by affecting TLR4/NF-κB and TLR4/MAPK signaling pathway in a mouse model

  2021cites this paper
• Orally Deliverable Dual-Targeted Pellets for the Synergistic Treatment of Ulcerative Colitis

  2021cites this paper
• Associations of Bitumen Fumes with Lymphocyte Subsets and Cytokines Expression in the Peripheral Blood of Exposed Workers.

  2021cites this paper
• Gamma-Oryzanol-Rich Fraction from Purple Rice Extract Attenuates Lipopolysaccharide-Stimulated Inflammatory Responses, Migration and VEGFA Production in SW480 Cells via Modulation of TLR4 and NF-κB Pathways

  2021cites this paper
• Transcriptome Profiling and Metagenomic Analysis Help to Elucidate Interactions in an Inflammation-Associated Cancer Mouse Model

  2021cites this paper
• Olfactomedin 4 is not a precise marker for human intestinal stem cells, but is involved in intestinal carcinogenesis.

  2021cites this paper
• Alteration of oxidative-stress and related marker levels in mouse colonic tissues and fecal microbiota structures with chronic ethanol administration: Implications for the pathogenesis of ethanol-related colorectal cancer

  2021cites this paper
• Therapeutic effects of dihydroartemisinin in multiple stages of colitis-associated colorectal cancer

  2021cites this paper
• Evaluation of Disease Index, Colon Damage Score, and Microbial Analysis of Intestinal Flora after Treatment with the Novel Test Formulation in TNBS-Induced Colitis in Sprague Dawley Rats

  2021cites this paper
• Toll-Interacting Protein Regulates Immune Cell Infiltration and Promotes Colitis-Associated Cancer

  2020cites this paper
• Similarities between the Yin/Yang Doctrine and Hormesis in Toxicology and Pharmacology

  2020cites this paper
• Ellagic acid protects Caco-2 cell monolayers against inflammation-induced permeabilization.

  2020cites this paper
• Anti-inflammatory properties and gut microbiota modulation of an alkali-soluble polysaccharide from purple sweet potato in DSS-induced colitis mice.

  2020cites this paper
• The gut microbiome and potential implications for early-onset colorectal cancer

  2020cites this paper
• Cancer Defenses in Humans and the Search for a Vaccine

  2020cites this paper
• Influence of Iron on the Gut Microbiota in Colorectal Cancer

  2020cites this paper
• Theracurmin inhibits intestinal polyp development in Apc‐mutant mice by inhibiting inflammation‐related factors

  2020cites this paper
• The Emerging Role of PPAR Beta/Delta in Tumor Angiogenesis

  2020cites this paper
• Promising Chemoprevention of Colonic Aberrant Crypt Foci by Portunus segnis Muscle and Shell Extracts in Azoxymethane-Induced Colorectal Cancer in Rats.

  2020cites this paper
• The risk of extra-intestinal cancer in inflammatory bowel disease: a systematic review and meta-analysis of population-based cohort studies.

  2020cites this paper
• Colorectal tumour characteristics and oncological outcome in patients with inflammatory bowel disease

  2020cites this paper
• Multiple outcome meta-analysis of gene-expression data in inflammatory bowel disease.

  2020cites this paper
• Cyclic derivative of morphiceptin Dmt-cyclo-(D-Lys-Phe-D-Pro-Asp)-NH2(P-317), a mixed agonist of MOP and KOP opioid receptors, exerts anti-inflammatory and anti-tumor activity in colitis and colitis-associated colorectal cancer in mice.

  2020cites this paper
• The IL-1 family cytokines and receptors in autoimmune diseases.

  2020cites this paper
• Andrographolide sulfonate ameliorates chronic colitis induced by TNBS in mice via decreasing inflammation and fibrosis.

  2020cites this paper
• Folate and Inflammation – links between folate and features of inflammatory conditions

  2019cites this paper
• Mediatory role of BLT2 in the proliferation of KRAS mutant colorectal cancer cells.

  2019cites this paper
• Autoimmunity and Cancer, the Paradox Comorbidities Challenging Therapy in the Context of Preexisting Autoimmunity

  2019influential citation
• Expression and association of carbonic anhydrase IX and cyclooxygenase-2 in colorectal cancer.

  2019cites this paper
• Regulatory T Cells and Plasmacytoid Dendritic Cells Within the Tumor Microenvironment in Gastric Cancer Are Correlated With Gastric Microbiota Dysbiosis: A Preliminary Study

  2019cites this paper
• Inflammation and Inflammatory Cytokine Contribute to the Initiation and Development of Ulcerative Colitis and Its Associated Cancer.

  2019cites this paper
• Dichotomous roles of claudins as tumor promoters or suppressors: lessons from knockout mice

  2019cites this paper
• The E3 Ubiquitin Ligase Asb2α in T Helper 2 Cells Negatively Regulates Antitumor Immunity in Colorectal Cancer

  2019cites this paper
• Abrogation of EMILIN1-β1 integrin interaction promotes experimental colitis and colon carcinogenesis.

  2019cites this paper
• Orally Deliverable Nanotherapeutics for the Synergistic Treatment of Colitis-Associated Colorectal Cancer

  2019cites this paper
• Impaired skin barrier function caused by reactive oxygen species in mice with colonic tumours

  2019cites this paper
• Anti-inflammatory Activity

  2018cites this paper
• Endogenous n-3 polyunsaturated fatty acids prevent azoxymethane-induced colon tumorigenesis in mice fed a high-fat diet

  2018cites this paper
• Regulatory T Cells in Colorectal Cancer

  2018cites this paper
• Vitamin D deficiency in the ApcPirc/+ rat does not exacerbate colonic tumorigenesis, while low dietary calcium might be protective

  2018cites this paper
• Chemoprevention of Colorectal Cancer by Dietary Compounds

  2018cites this paper
• Th17 cell-derived IL-17A promoted tumor progression via STAT3/NF-κB/Notch1 signaling in non-small cell lung cancer

  2018cites this paper
• Gastric Protective Activities of Sea Cucumber Fucoidans with Different Molecular Weight and Chain Conformations: A Structure-Activity Relationship Investigation.

  2018cites this paper
• COLORECTAL CARCINOMAS IN NATIONAL HOSPITAL ABUJA, NIGERIA

  2018cites this paper
• Anti-ulcer effect of Gallarhois extract with anti-oxidant activity in an ICR model of ethanol/hydrochloride acid-induced gastric injury

  2018cites this paper
• NF-κB potentiates tumor growth by suppressing a novel target LPTS

  2017cites this paper
• A food-based approach that targets interleukin-6, a key regulator of chronic intestinal inflammation and colon carcinogenesis.

  2017cites this paper
• Perilla frutescens Extracts Protects against Dextran Sulfate Sodium-Induced Murine Colitis: NF-κB, STAT3, and Nrf2 as Putative Targets

  2017cites this paper
• Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma

  2017cites this paper
• Inflammatory Biomarkers for Cancer

  2017cites this paper
• Anti-inflammatory effect of lycopene in SW480 human colorectal cancer cells

  2017influential citation
• Increase in dietary protein content exacerbates colonic inflammation and tumorigenesis in azoxymethane-induced mouse colon carcinogenesis

  2017cites this paper
• Involvement of CRF2 signaling in enterocyte differentiation

  2017cites this paper
• Changes in the Luminal Environment of the Colonic Epithelial Cells and Physiopathological Consequences.

  2017cites this paper
• Imatinib and its combination with 2,5-dimethyl-celecoxibinduces apoptosis of human HT-29 colorectal cancer cells

  2017cites this paper
• SHP2 associates with nuclear localization of STAT3: significance in progression and prognosis of colorectal cancer

  2017cites this paper
• Epigenetic Effects of Gut Microbiota on Obesity and Gastrointestinal Cancers

  2016cites this paper
• Wogonoside prevents colitis-associated colorectal carcinogenesis and colon cancer progression in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway

  2016cites this paper
• ROLE OF INTESTINAL CX3CR1+ MACROPHAGES IN THE DEVELOPMENT OF COLITIS-ASSOCIATED CANCER: FOCUS ON THE RELEVANCE OF THE MICROBIOME AND HEME-OXYGENASE-1

  2016cites this paper
• Identification and verification of PRDX1 as an inflammation marker for colorectal cancer progression.

  2016cites this paper
• Hydrostatin-TL1, an Anti-Inflammatory Active Peptide from the Venom Gland of Hydrophis cyanocinctus in the South China Sea

  2016cites this paper
• Intermolecular disulfide bond influences unphosphorylated STAT3 dimerization and function.

  2016cites this paper
• AOM/DSS Model of Colitis-Associated Cancer.

  2016cites this paper
• Therapeutic effect of hydroxychloroquine on colorectal carcinogenesis in experimental murine colitis.

  2016cites this paper
• Anti-ulcerogenic effect of cavidine against ethanol-induced acute gastric ulcer in mice and possible underlying mechanism.

  2016cites this paper
• The recent progress of the mechanism and regulation of tumor necrosis in colorectal cancer

  2016cites this paper
• Apolipoprotein A-I inhibits experimental colitis and colitis-propelled carcinogenesis

  2016cites this paper
• Hypoxia-inducible factors: key regulators of myeloid cells during inflammation.

  2016cites this paper
• Concerted actions of ameliorated colitis, aberrant crypt foci inhibition and 15‐hydroxyprostaglandin dehydrogenase induction by sonic hedgehog inhibitor led to prevention of colitis‐associated cancer

  2016cites this paper